Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Marksans Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199208-08-2013
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Marksans Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Mark Saldanha has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSEFinancial Results & Limited Review for June 30, 2013
Marksans Pharma Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended June 30, 2013.Updates
Marksans Pharma Ltd has informed BSE that:- The Company was registered with BIFR under SICA.In this connection, the Company has informed that, the Company has been de-registered from the purview of SICA and is no longer in BIFR as per the directions of the Honble BIFR in its hearing held on July 17, 2013. The summary record of proceedings of the hearing is awaited".Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Marksans Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Marksans Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Mark Saldanha has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSEDisclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Mark Saldanha has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSEFinancial Results & Auditors Report for March 31, 2013 (Audited)
Marksans Pharma Ltd has informed BSE about the Financial Results & a copy of the Auditors Report for the period ended March 31, 2013.